| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission 1 These results have been reported in part in two publications (Haddjeri et al. 1996, 1997). 1
|
Haddjeri, Nasser
|
|
1998
|
51 |
3 |
p. 255-266
12 p.
|
article
|
| 2 |
Clinical pharmacology of befloxatone: a brief review
|
Rosenzweig, P
|
|
1998
|
51 |
3 |
p. 305-312
8 p.
|
article
|
| 3 |
Editorial
|
|
|
1998
|
51 |
3 |
p. 211-213
3 p.
|
article
|
| 4 |
Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder
|
Pinto, Olavo C
|
|
1998
|
51 |
3 |
p. 333-343
11 p.
|
article
|
| 5 |
Mechanism of action of serotonin selective reuptake inhibitors
|
Stahl, Stephen M.
|
|
1998
|
51 |
3 |
p. 215-235
21 p.
|
article
|
| 6 |
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion
|
Horst, W.Dale
|
|
1998
|
51 |
3 |
p. 237-254
18 p.
|
article
|
| 7 |
Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide
|
Versiani, Marcio
|
|
1998
|
51 |
3 |
p. 323-332
10 p.
|
article
|
| 8 |
Preclinical profile of befloxatone, a new reversible MAO-A inhibitor
|
Curet, O.
|
|
1998
|
51 |
3 |
p. 287-303
17 p.
|
article
|
| 9 |
Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
|
Fawcett, Jan
|
|
1998
|
51 |
3 |
p. 267-285
19 p.
|
article
|
| 10 |
The clinical pharmacologic profile of reboxetine: does it involve the putative neurobiological substrates of wellbeing?
|
Healy, David
|
|
1998
|
51 |
3 |
p. 313-322
10 p.
|
article
|
| 11 |
The scientific, quasi-scientific and popular literature on the use of St. John’s Wort in the treatment of depression
|
Deltito, Joseph
|
|
1998
|
51 |
3 |
p. 345-351
7 p.
|
article
|
Journal description